-The Hindustan Times Prime Minister Manmohan Singh has aptly described the persistence of mass undernutrition in India as a "national shame". What is even more shameful, however, is the passivity of the government - and of the country - towards this humanitarian emergency. The passivity begins with a reluctance to face the facts. The first step towards more effective nutrition policies in India is regular monitoring of the nutrition status of...
More »SEARCH RESULT
The Political Economy of Shadow Finance in West Bengal-Subhanil Chowdhury
-Economic and Political Weekly The Saradha group's collapse has possibly bankrupted lakhs of small investors robbing them of their life svaings, and has rendered thousands of its agents jobless. The scam highlights the failure of the government and its regulatory agencies to reign in the mushrooming chit fund companies in West Bengal. It also brings under the scanner the Trinamool Congress' proximity with the tainted group. In the wake of the...
More »Dismal Dalit Count in Indian Boardrooms
Guess what is the total percentage of dalit or tribal members in the boards of big Indian private and public sector companies listed on the stock exchange? Well, shocking as it might be, the real count is nearly zero. A fresh study conducted by D Ajit, Han Donker and Ravi Saxena reveals that at a time when the issues of ethnic and racial inequalities is being discussed all over the world,...
More »PM says unauthorized deposit collection has to be curbed
-The Times of India Prime Minister Manmohan Singh said on Saturday that unauthorized collection of deposits promising high returns has to be curbed as the Centre unleashed a multi-agency probe on chit funds and money pooling firms in West Bengal and the eastern region. Rattled by the collapse of the Saradha group in West Bengal, the Centre has asked various agencies such as the Enforcement Directorate (ED), Income Tax department, the ministry...
More »The Cost of Drugs: Beyond the Supreme Court Order -Sanjay Nagral
-Economic and Political Weekly While the Supreme Court decision in the recent Novartis case has cleared the way for production of generic drugs in India, doctors have to prescribe cheaper alternatives to costly brands if patients with limited means are to benefit. What is being hailed as a victory in the struggle for affordable medicines in the country will actually be one only when there is a pro-patient slant to the...
More »